跳至主要内容
临床试验/ISRCTN27478455
ISRCTN27478455已完成不适用

A randomised study of continuous infusional 5-fluorouracil with or without bolus mitomycin-C in patients with advanced colorectal cancer

The Royal Marsden NHS Foundation Trust (UK)0 个研究点目标入组 200 人开始时间: 2002年8月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Histological evidence of metastatic adenocarcinoma of the colon or rectum not amenable to surgery or radiotherapy
  • 2. Patients evaluable for response must have bi-dimensionally measurable disease
  • 3. Patients with no measurable disease
  • 4. Adequate bone marrow function
  • 5. Serum creatinine within normal range
  • 6. Life expectancy of greater than 3 months
  • 7. Eastern Cooperative Oncology Group (ECOG) performance status 0-2

排除标准

  • 1. History of other malignant disease other than non melanotic skin cancer or carcinoma in situ of the cervix
  • 2. Prior treatment with any cytotoxic agent except adjuvant chemotherapy completed more than 12 months from randomisation
  • 3. Intracerebral metastases or meningeal carcinomatosis
  • 4. Medical contraindications to treatment

研究者

发起方
The Royal Marsden NHS Foundation Trust (UK)

相似试验